These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32186248)

  • 1. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
    Agarwal S; Kashaw SK
    J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water Mapping and Scoring Approaches to Predict the Role of Hydration Sites in the Binding Affinity of PAK1 Inhibitors.
    Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangasamy R; Poopandi S; Jeyakanthan J
    Comb Chem High Throughput Screen; 2022; 25(4):660-676. PubMed ID: 33687876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand and structure based virtual screening of chemical databases to explore potent small molecule inhibitors against breast invasive carcinoma using recent computational technologies.
    Agarwal S; Dixit A; Kashaw SK
    J Mol Graph Model; 2020 Jul; 98():107591. PubMed ID: 32234678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma.
    Yellapu NK; Pulaganti M; Pakala SB
    J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Pak1 inhibitors using water thermodynamic analysis.
    Biswal J; Jayaprakash P; Suresh Kumar R; Venkatraman G; Poopandi S; Rangasamy R; Jeyaraman J
    J Biomol Struct Dyn; 2020 Jan; 38(1):13-31. PubMed ID: 30661460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potential HER2 inhibitors from
    Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
    J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of small molecule inhibitors of RAD52 for breast cancer therapy: in silico approach.
    Kumar M; Dubey R; Kumar Shukla P; Dayal D; Kumar Chaubey K; Tsai LW; Kumar S
    J Biomol Struct Dyn; 2024 Jun; 42(9):4605-4618. PubMed ID: 37288783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential inhibitors of HER2 targeting breast cancer-a structure-based drug design approach.
    Singh G; Al-Fahad D; Al-Zrkani MK; Chaudhuri TK; Soni H; Tandon S; Narasimhaji CV; Azam F; Patil R
    J Biomol Struct Dyn; 2024 Sep; 42(15):8184-8201. PubMed ID: 37565730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1).
    Shahinozzaman M; Ishii T; Ahmed S; Halim MA; Tawata S
    J Biomol Struct Dyn; 2020 Aug; 38(12):3514-3526. PubMed ID: 31448698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
    Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
    Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation.
    Su Y; Song P; Wang H; Hu B; Wang J; Cheng MS
    J Biomol Struct Dyn; 2020 Aug; 38(13):3825-3837. PubMed ID: 31490101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WaterMap and Molecular Dynamic Simulation-Guided Discovery of Potential PAK1 Inhibitors Using Repurposing Approaches.
    Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangaswamy R; Jeyaraman J
    ACS Omega; 2021 Oct; 6(41):26829-26845. PubMed ID: 34693105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
    Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
    J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting homologous recombination (HR) repair mechanism for cancer treatment: discovery of new potential UCHL-3 inhibitors
    Alakhdar AA; Saleh AH; Arafa RK
    J Biomol Struct Dyn; 2022 Jan; 40(1):276-289. PubMed ID: 32851933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
    Rezvani S; Ebadi A; Razzaghi-Asl N
    J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
    J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Targeting Human Multidrug Transporter ABCG2 in Breast Cancer: Database Screening, Molecular Docking, and Molecular Dynamics Study.
    Ibrahim MAA; Badr EAA; Abdelrahman AHM; Almansour NM; Mekhemer GAH; Shawky AM; Moustafa MF; Atia MAM
    Mol Inform; 2022 Feb; 41(2):e2060039. PubMed ID: 34491628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated computational approach to screening of alkaloids inhibitors of TBX3 in breast cancer cell lines.
    Paul A; Limon MBH; Hossain MM; Raza MT
    J Biomol Struct Dyn; 2023 Apr; 41(7):3025-3041. PubMed ID: 35253621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.